Dyne Therapeutics Inc (DYN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -40.15M | -45.46M | -66.74M | -62.27M | -67.69M | -69.16M | -71.96M | -105.66M |
| Pre Tax Income | -38.83M | -44.19M | -64.9M | -60.21M | -66.64M | -65.65M | -65.1M | -97.13M |
| Net Income | -38.83M | -44.19M | -64.9M | -60.21M | -66.64M | -65.65M | -65.1M | -97.13M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -40.17M | -45.68M | -67.11M | -62.4M | -68.39M | -68.65M | -72.15M | -106.11M |
| EBITDA | -39.74M | -45.05M | -66.31M | -61.84M | -67.29M | -68.77M | -71.56M | -105.22M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.8M | -13.83M | -58.65M | -150.03M | -170.96M | -242.16M |
| Pre Tax Income | -4.81M | -14.86M | -59.44M | -149.29M | -168.1M | -235.94M |
| Net Income | -4.81M | -14.86M | -59.44M | -149.29M | -168.1M | -235.94M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.28 | -5.744 | -1.319 | -2.893 | -3.238 | -3.844 |
| EBIT | -4.82M | -15.15M | -59.1M | -150.03M | -171.02M | -243.58M |
| EBITDA | -4.77M | -13.56M | -57.95M | -148.94M | -169.28M | -240.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
